thiazolidinediones
Troglitazone is the first of a new group of oral antidiabetic drugs, the       thiazolidinediones, and is indicated for the treatment of patients with type 2       (non-insulin-dependent) diabetes mellitus.
Troglitazone is the first of a new group of oral  @OBJECT$  @PREDICAT$  @SUBJECT$ , and is indicated for the treatment of patients with type 2       (non-insulin-dependent) diabetes mellitus.